0
0
0
0
1
2
3
$0
Is Gilead solid or fragile? The Finex Financial Health Scanner reads GILD's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $29.4B |
|---|---|
| Net income | $8.5B |
| Operating margin | 34.0% |
| Net margin | 28.9% |
| Cash and investments | $7.6B |
| Total debt | $24.9B |
| Free cash flow | $10.7B |
| Revenue growth (1 year) | 2.4% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.